2025-523101-15-00招募中1 期
First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Genmab A/S
- 入组人数
- 16
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Trial Information
Scientific
Genmab A/S
研究点 (2)
Loading locations...
相似试验
招募中
1 期
A Phase 1 Study of JNJ-87562761 in Relapsed/Refractory Multiple Myeloma2024-513439-25-00Janssen Cilag International15
招募中
1 期
A Phase 1 Prospective, Open-label, First-in-human Study to Evaluate the Safety, Tolerability and Biodistribution of [177Lu]Lu-AKIR001 and its Anti-tumour Effect in Adult Patients with CD44v6 Expressing Solid Tumours2023-508126-95-00Karolinska University Hospital30
招募中
1 期
Phase I study of IAG933 in patients with advanced Mesothelioma and other solid tumors2023-508369-34-00Novartis Pharma AG89
已完成
1 期
Phase 1b study to evaluate MK 0482 for Relapsed/Refractory AML/CMML2023-503580-42-00Merck Sharp & Dohme LLC15
招募中
2 期
A phase I/II trial of TG4050, an individualised gene therapy, in patients with advanced cancer of the head and neck.2023-508561-33-00Transgene98